lung cancer

Chemotherapy has been the mainstay for lung cancer treatment for decades. Unfortunately, even after an initial positive response to it, tumors can sometimes develop drug resistance. When this happens, there is little doctors can do to improve a patient’s outcome, as the survival rate after relapse can be devastatingly low. Understanding exactly what causes this cancer to rebound has scientists taking a closer look at the genetic diversity of lung tumors, in particular their epigenetic signature. In recent years, genomic [more…]

Cancer is a complex disease influenced by numerous factors including genetic make-up, lifestyle, and the environment. Over the years, the growing field of epigenetics has greatly contributed to our understanding of cancer and tumor progression. It has also led to the development of novel drug therapies. Yet, despite the fact that epigenetic regulators have become attractive anticancer targets, many scientists believe that extra caution should be taken when assessing their overall effects. In a new study, one potential epigenetic therapy [more…]